Adherence, Diversion, & Misuse

Provides guidance about the use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with or at risk of addiction. Links to additional resources, such as a pocket guide and a slide deck.

Provides an overview of how organizations can use NIATx practices and tools to implement or improve a buprenorphine treatment program.

Provides guidance to physicians and pharmacists on buprenorphine regulatory requirements, prescribing, dispensing, and safety recommendations and additional information to improve decision making and promote beneficial outcomes.

These are slides from a webinar which provided an overview of how drug diversion is a significant risk for patients and institutions and addresses why institutions should have a program in place to detect diversion.